New research backed up previous findings, showing a substantially higher risk for severe hypocalcemia in older patients on kidney dialysis than in those treated with oral bisphosphonates.
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney disease.
Fifteen percent of Americans have chronic kidney disease, so why do only 10% know about it? Primary care clinicians can and should be doing more to identify patients.
Gestational diabetes raises the risk for future chronic kidney disease, a risk heightened by subsequent diabetes or hypertension, found an analysis of Danish registry data.